— Stitch Fix (NASDAQ: SFIX) reported second quarter 2020 earnings of $0.11 per share vs. $0.06 expected.
— Revenue rose 22% year-over-year to $451.8 million vs. $452.53 million expected.
— Active clients increased 17% annually to 3.5 million. Net revenue per active client grew 8% to $501.
— With regards to the coronavirus outbreak, the company said, “We recognize this is a dynamic situation and, while it’s too early for us to quantify total potential supply chain or client demand impact at this point, it’s reasonable to expect that we’ll see some impact.”
— Stitch Fix reduced its fiscal year 2020 revenue growth outlook to a range of 17-19% on a 52-week basis from the previously announced revenue growth outlook of 23–25%. Revenue is expected to be in the range of $1.81 billion to $1.84 billion for FY20.
— For the third quarter of 2020, revenue is targeted to be in the range of $465 million to $475 million, representing a year-over-year growth of 14-16%.
— SFIX stock cratered about 40% during the extended trading hours.
Most Popular
Nike (NKE) looks set to beat hurdles and build a brighter future
Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business
Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company
Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as
Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications
